Table 2.
Use of Automated Antimicrobial Susceptibility Testing Methods Among Participant Laboratories in This Study
| Organism | Antimicrobial Agent | United States | International | ||
|---|---|---|---|---|---|
| Total No. of Laboratories | % Automated Method | Total No. of Laboratories | % Automated Method | ||
| Enterobacterales | Ceftazidime | 1018 | 98.6 | 194 | 93.3 |
| Enterobacterales | Ceftriaxone | 1101 | 98.8 | 180 | 92.2 |
| Enterobacterales | Ciprofloxacin | 1022 | 97.4 | 198 | 92.9 |
| Enterobacterales | Levofloxacin | 977 | 97.1 | 153 | 88.9 |
| Enterobacterales | Meropenem | 944 | 97.4 | 180 | 91.7 |
| Pseudomonas aeruginosa | Piperacillin-tazobactam | 1029 | 96.7 | 186 | 91.4 |
| Acinetobacter baumannii | Imipenem | 743 | 95.3 | 154 | 89.5 |